Generation Bio Reports Third Quarter 2020 Business Updates and Financial Results
Nov 10, 2020 - GlobeNewswire
Board and Executive Moves-Event Announcements-Financial Results
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO) is an innovative genetic medicines company creating a new class of non-viral gene therapy. Today the company reported recent business highlights and third quarter financial results.
“2020 continues to be a year of progress and execution for Generation Bio as we advance our non-viral gene therapy approach,” said Geoff McDonough, M.D., president and chief executive officer of Generation Bio. “Des...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
